| Trial ID: | L0206 |
| Source ID: | NCT01919294
|
| Associated Drug: |
Testosterone undecanoate
|
| Title: |
Testosterone Replacement in Non-alcoholic Steatohepatitis (TEREPINS)
|
| Acronym: |
TEREPINS
|
| Status: |
Completed
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Nonalcoholic Steatohepatitis|Hypogonadism
|
| Interventions: |
Drug: testosterone undecanoate
|
| Outcome Measures: |
steatosis histology|Proportion of patients in whom liver inflammation improves|Proportion of patients in whom liver ballooning improves|Proportion of patients in whom liver fibrosis improves|Change in fat content of liver|Change in HOMA index|Change in serum liver enzymes|Adverse events
|
| Sponsor/Collaborators: |
Sheffield Teaching Hospitals NHS Foundation Trust|Bayer
|
| Gender: |
Male
|
| Age: |
18 Years to 75 Years ?? (Adult, Older Adult)
|
| Phases: |
Phase 2
|
| Enrollment: |
3
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment
|
| Start Date: |
July 2013
|
| Completion Date: |
January 30, 2017
|
| Results First Posted: |
--
|
| Last Update Posted: |
April 26, 2017
|
| Locations: |
Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, South Yorkshire, United Kingdom
|
| URL: |
https://ClinicalTrials.gov/show/NCT01919294
|
